Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (411-420 of 595) with videos related to

Pageof 60
Sort By:
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Leukemia|December 25, 2004
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignanciesM D Odero, F H Grand, S Iqbal, et al.
Blood|November 5, 2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsJoannah Score, Claire Hidalgo-Curtis, Amy V Jones, et al.
British Journal of Haematology|July 30, 2013
Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionMarta Fernandez-Mercado, Andrea Pellagatti, Cristina Di Genua, et al.
Blood|February 2, 2006
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapyJaspal Kaeda, Derville O'Shea, Richard M Szydlo, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
Acta Psychiatrica Scandinavica|September 11, 2024
A national evaluation of a multi-modal, blended, digital intervention integrated within Australian youth mental health servicesM Alvarez-Jimenez, J Nicholas, L Valentine, et al.
Pageof 60

Showing results (411-420 of 595) with videos related to

Sort By:
Pageof 60
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Leukemia|December 25, 2004
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignanciesM D Odero, F H Grand, S Iqbal, et al.
Blood|November 5, 2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsJoannah Score, Claire Hidalgo-Curtis, Amy V Jones, et al.
British Journal of Haematology|July 30, 2013
Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionMarta Fernandez-Mercado, Andrea Pellagatti, Cristina Di Genua, et al.
Blood|February 2, 2006
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapyJaspal Kaeda, Derville O'Shea, Richard M Szydlo, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
Acta Psychiatrica Scandinavica|September 11, 2024
A national evaluation of a multi-modal, blended, digital intervention integrated within Australian youth mental health servicesM Alvarez-Jimenez, J Nicholas, L Valentine, et al.
Pageof 60